Augustine Biomedical & Design, LLC

Form 483 issued January 4, 2017 · Bloomington, Minnesota

Inspection
Dec 13, 2016 – Jan 4, 2017
Observations
1
Pages
3
FEI number
3005857264

In short: On January 4, 2017, FDA issued a Form 483 with 1 observation to Augustine Biomedical & Design, LLC in Bloomington, Minnesota (FEI 3005857264) after an inspection that ran Dec 13, 2016 – Jan 4, 2017. The investigator was Marissa S. Steinhagen. Most observations concern cAPA; the most-cited regulation is 21 CFR 820.198 (complaint files).

At a glance

1 of 1 observations on this 483 concern capa.

CAPA1

Most cited: 21 CFR 820.198(a) (1×)

What FDA observed

Preview: the opening words of each observation
  1. 01

    Procedures for receiving, reviewing, and evaluating complaints by a formally designated unit have…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Augustine Biomedical & Design, LLC?

FDA listed 1 observation on this Form 483, mostly about cAPA. The most-cited regulation is 21 CFR 820.198 (complaint files). The opening words of each observation are shown on this page.

Who inspected Augustine Biomedical & Design, LLC?

Marissa S. Steinhagen is named on this Form 483, for the inspection of Dec 13, 2016 – Jan 4, 2017. Each investigator has a profile showing what they cite most.

When was Augustine Biomedical & Design, LLC inspected by FDA?

The inspection ran Dec 13, 2016 – Jan 4, 2017, and the Form 483 is dated January 4, 2017.

How do I get the full Form 483 for Augustine Biomedical & Design, LLC?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free